The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD - Concepedia

Concepedia

Publication | Closed Access

The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD

86

Citations

11

References

2015

Year

A. Kirsten, Karin Förster, E. Radeczky, Anneliese Linnhoff, Beatrix Bálint, Henrik Watz, Heather Wray, Lynette Salkeld, Marie Cullberg, B. Larsson

Pulmonary Pharmacology & Therapeutics

Advanced Lung DiseasePulmonary PharmacologyPulmonary MedicinePharmacotherapySelective Cxcr2 AntagonistMedicineOral Azd5069Moderate-to-severe CopdPulmonary Disease

References

	Year	Citations

Page 1

Page 1